:root > g > circle{ fill: #fff; } A UNIQUE BIOPHARMA SPAC Jiya Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) affiliated with Samsara BioCapital, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Jiya intends to capitalize on its team’s expertise, network, reputation, and track record to identify promising opportunities in the biopharmaceutical sector. © 2021 Jiya Acquisition Corp All rights reserved. Privacy Policy 628 Middlefield Road Palo Alto, CA 94301 info@jiyacorp.com 650-285-4270 connect

INVESTOR RELATIONS NASDAQ: JYAC PRESS RELEASES November 18, 2020 Palo Alto – November 18, 2020 – Jiya Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar […] GOVERNANCE DOCUMENTS Audit Committee Charter Nominating & Governance Committee Charter Compensation Committee Charter Code of Ethics Insider Trading Policy Corporate Governance Guidelines SEC FILINGS EDGAR © 2021 Jiya Acquisition Corp All rights reserved. Privacy Policy 628 Middlefield Road Palo Alto, CA 94301 info@jiyacorp.com 650-285-4270 connect

TEAM SRINIVAS AKKARAJU, M.D., PH.D. Chairman of the Board REKHA HEMRAJANI Chief Executive Officer & Director MAYANK GANDHI, MD VP, Corporate Development CORY S. FREEDLAND, PH.D. Chief Investment Officer & Director RICHARD VAN DOREN Chief Financial Officer & Director LORI FRIEDMAN, PH.D. Director PAMELA KLEIN, MD Director DAN SPIEGELMAN Director STEVE KELSEY, MD Director GRAHAM BRAZIER Strategic Advisor © 2021 Jiya Acquisition Corp All rights reserved. Privacy Policy 628 Middlefield Road Palo Alto, CA 94301 info@jiyacorp.com 650-285-4270 connect